Cytocore Inc Revenue Growth Rates (CYOE), Current and Historic Growth - CSIMarket
CSIMarket
 


Cytocore Inc  (CYOE)
 

CYOE's Revenue Growth by Quarter and Year

Cytocore Inc's Revenue results by quarter and year




CYOE Revenue (in millions $) FY 2014 FY 2013 FY 2012 FY 2011
4th Quarter December -
3rd Quarter September 2.79
2nd Quarter June 3.18
1st Quarter March 0.00
FY 5.97





CYOE Revenue third quarter 2014 Y/Y Growth Comment
Cytocore Inc achieved in the third quarter 2014, above Company average Revenue surge of 27750% year on year, to $ 2.79 millions.

According to the results reported in the third quarter 2014, Cytocore Inc achieved the best Revenue growth in Laboratory Analytical Instruments industry. While Cytocore Inc' s Revenue doubling of 27750% ranks overall at the positon no. 19 in the third quarter 2014.




CYOE Revenue ( Y/Y Growth %) 2014
2013 2012 2011
4th Quarter December - - - -
3rd Quarter September 27750 % -83.33 % 500 % 0 %
2nd Quarter June - - 1000 % -
1st Quarter March - -50 % 100 % -
FY   - -90 % 566.67 % -

Financial Statements
Cytocore Inc's third quarter 2014 Revenue $ 2.79 millions CYOE's Income Statement
Cytocore Inc's third quarter 2013 Revenue $ 0.01 millions Quarterly CYOE's Income Statement


CYOE Revenue (Quarter on Quarter Growth %)

2014
2013 2012 2011
4th Quarter December - - -83.33 % -
3rd Quarter September -12.42 % - -45.45 % 0 %
2nd Quarter June - - 450 % 0 %
1st Quarter March - 0 % - 0 %
FY (Year on Year)   - -90 % 566.67 % -




Revenue third quarter 2014 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #1
Healthcare Sector #5
Overall #19

Revenue Y/Y Growth Statistics
High Average Low
79275 % 11437.03 % -96.23 %
(Jun 30 2014)   (Jun 30 2013)
Revenue third quarter 2014 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #1
Healthcare Sector #5
Overall #19
Revenue Y/Y Growth Statistics
High Average Low
79275 % 11437.03 % -96.23 %
(Jun 30 2014)   (Jun 30 2013)

Revenue by Quarter for the Fiscal Years 2011, 2012, 2013, 2014

Cytocore Inc's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
105733.33 % 7555.48 % -100 %
(Jun 30 2014)  


CYOE's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2014 Cytocore Inc disclosed drop in Revenue from the second quarter by -12.42% to $ 2.79 millions, from $ 3.18 millions achived in the previous reporting period.

Within Laboratory Analytical Instruments industry 20 other companies have achieved higher Revenue quarter on quarter growth. While Cytocore Inc's Revenue growth quarter on quarter, overall rank is 3719.


Revenue Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #21
Healthcare Sector #429
Overall #3719
Revenue Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #21
Healthcare Sector #429
Overall #3719
Revenue Q/Q Growth Statistics
High Average Low
105733.33 % 7555.48 % -100 %
(Jun 30 2014)  


CYOE's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2014 Cytocore Inc disclosed drop in Revenue from the second quarter by -12.42% to $ 2.79 millions, from $ 3.18 millions achived in the previous reporting period.

Within Laboratory Analytical Instruments industry 20 other companies have achieved higher Revenue quarter on quarter growth. While Cytocore Inc's Revenue growth quarter on quarter, overall rank is 3719.


Cytocore Inc's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2014)
12 Months Ending
(Jun 30 2014)
12 Months Ending
(Mar 31 2014)
12 Months Ending
(Dec 31 2013)
12 Months Ending
(Sep 30 2013)
Cumulative Revenue 12 Months Ending $ 5.97 $ 3.19 $ 0.02 $ 0.02 $ 0.03
Y / Y Revenue Growth (TTM) 22000 % 3739.76 % -91.35 % -87.88 % -
Year on Year Revenue Growth Overall Ranking # 3008 # 0 # 0 # 0 # 0
Seqeuential Revenue Change (TTM) 87.23 % 19818.75 % -33.33 % -11.11 % -67.47 %
Seq. Revenue Growth (TTM) Overall Ranking # 2973 # 63 # 0 # 0 # 2553


Cumulative Revenue growth Comment
With 22000% annual Revenue growth, Cytocore Inc would report a record annual Revenue surge if the fiscal year would end on Sep 30 2014.

In the Healthcare sector 321 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 3008.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 23
Healthcare Sector # 322
Overall # 3008

Revenue TTM Y/Y Growth Statistics
High Average Low
22000 %
6390.13 %
-91.35 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 23
Sector # 317
S&P 500 # 2973
Cumulative Revenue growth Comment
With 22000% annual Revenue growth, Cytocore Inc would report a record annual Revenue surge if the fiscal year would end on Sep 30 2014.

In the Healthcare sector 321 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 3008.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 23
Healthcare Sector # 322
Overall # 3008

Revenue TTM Y/Y Growth Statistics
High Average Low
22000 %
6390.13 %
-91.35 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 23
Sector # 317
S&P 500 # 2973




Other Revenue Growth
Laboratory Analytical Instruments Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
CYOE's Revenue Growth Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue surge for the quarter ending Sep 30 2014 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2014
Harrow Inc 17,541.20%$ 17,541.200 millions


About Cytocore Inc Revenue Growth Rates (CYOE), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.